Departments of Neurosurgery, Mayo Clinic, Rochester, MN 55905, USA.
AJNR Am J Neuroradiol. 2012 Dec;33(11):2158-61. doi: 10.3174/ajnr.A3207. Epub 2012 Jul 12.
Flow diversion is a new strategy for the treatment of complex paraclinoid aneurysms. However, flow diverters have, to date, not been tested in direct comparison with other available treatments. We present a matched-pair comparison of paraclinoid aneurysms treated with the PED versus other endovascular techniques.
Twenty-one eligible patients with 22 paraclinoid aneurysms treated with the PED at our institution were matched with historic controls with aneurysms of similar size and location.
There were no statistically significant differences between the 2 groups in terms of aneurysm size, location, risk factors, or comorbidities. Mean dome size was 13.9 ± 6.7 mm in the control group and 14.9 ± 6.3 mm in the PED group (P = .52). Balloon and stent assistance were used in 31.8% and 9.1% of controls, respectively, while carotid sacrifice was used in 36.4% of the controls. There was a significant difference in the rate of complete occlusion favoring PED at radiologic follow-up (P = .03).
Flow diverters achieve a much higher rate of complete angiographic obliteration compared with other standard endovascular techniques in the treatment of internal carotid artery aneurysms. In this series, this higher angiographic obliteration rate did not occur at the expense of an increased rate of complications. Careful long-term follow-up is of the utmost importance to definitively validate flow diversion as a superior therapeutic strategy for proximal internal carotid artery aneurysms.
血流导向装置是治疗复杂颈内动脉床突旁动脉瘤的新策略。然而,迄今为止,血流导向装置尚未与其他可用的治疗方法进行直接比较。我们报告了使用PED 与其他血管内技术治疗床突旁动脉瘤的配对比较。
在我们的机构中,有 21 名符合条件的患者的 22 个床突旁动脉瘤接受了 PED 治疗,这些患者与具有相似大小和位置的动脉瘤的历史对照组相匹配。
两组患者在动脉瘤大小、位置、危险因素或合并症方面均无统计学差异。对照组平均瘤顶大小为 13.9±6.7mm,PED 组为 14.9±6.3mm(P=0.52)。对照组中分别有 31.8%和 9.1%的患者使用了球囊和支架辅助,而对照组中有 36.4%的患者使用了颈动脉牺牲。在放射随访时,PED 完全闭塞的比例明显更高(P=0.03)。
与其他标准血管内技术相比,血流导向装置在治疗颈内动脉动脉瘤时能达到更高的完全血管造影闭塞率。在本系列中,这种更高的血管造影闭塞率并未导致并发症发生率增加。仔细的长期随访对于明确验证血流导向装置作为近端颈内动脉动脉瘤的优越治疗策略至关重要。